← Back to headlines
Johnson & Johnson's Spravato sales growth boosts psychedelics market outlook
Strong sales growth for Johnson & Johnson's Spravato, a nasal spray for treatment-resistant depression, is seen as a positive indicator for other companies developing psychedelic-based therapies.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
